FAS and prostate carcinoma: Fas-sensitive PC-3 prostate cancer cells were reported to be more sensitive to TNFα-mediated apoptosis and growth inhibition than Fas-resistant DU145 and LNCaP cells (Rokhlin et al., 1997).